Figure 3.

Cumulative hazard for escalation of medical therapy in response to uncontrolled IBD between patients receiving or not receiving SSRIs.

Cumulative hazard for escalation of medical therapy in response to uncontrolled IBD between patients receiving or not receiving SSRIs.